Allergic Rhinitis.

Area of Science:

• Allergy and Immunology
• Pediatrics
• Public Health

Background:

• Allergic rhinitis (AR) is a widespread chronic condition affecting over 400 million people globally.
• Childhood AR is rising, with many cases starting before age six, impacting quality of life and academic performance.
• Disparities exist, as underserved populations show higher sensitization rates but are likely underdiagnosed, worsening healthcare inequities.

Purpose of the Study:

• To highlight the prevalence and impact of allergic rhinitis in children.
• To discuss the diagnostic challenges and treatment advancements for pediatric AR.
• To emphasize the importance of specialist referral for moderate-to-severe or refractory cases.

Main Methods:

• Review of current literature on allergic rhinitis prevalence, diagnosis, and treatment in pediatric populations.
• Analysis of pharmacotherapy options, including intranasal corticosteroids, antihistamines, and oral antihistamines.
• Evaluation of allergen immunotherapy (subcutaneous and sublingual) and biological therapies for pediatric AR management.

Main Results:

• Pharmacotherapy options for pediatric AR have expanded significantly.
• Allergen immunotherapy offers disease-modifying effects, potentially preventing asthma development.
• Biological therapies used for asthma and atopic diseases can also alleviate AR symptoms.

Conclusions:

• Effective management of AR in children requires accurate diagnosis, considering both seasonal and perennial types.
• Allergen immunotherapy and biological treatments represent advanced options for refractory pediatric AR.
• Referral to allergists is recommended for comprehensive diagnosis and management, including specialized treatments.